1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Formoterol Fumarate Dihydrate | 富马酸福莫特罗 | 183814-30-4 |
| Budesonide | 布地奈德 | 51333-22-3 |
| Mometasone Furoate | 糠酸莫米松无水物 | 83919-23-7 |
| Fluticasone Propionate | 丙酸氟替卡松 | 80474-14-2 |
| Sulconazole Nitrate | 硝酸硫康唑 | 61318-91-0 |
| 3-(4-Hexyloxy-1,2,5-Thiadiazol-3-Yl) Pyridine | 3-(4-已氧基-1,2,5 -噻二唑-3-基) 吡啶 | 131987-69-4 |
| Fluvoxamine Maleate | 马来酸氟伏沙明 | 61718-82-9 |
| Salmeterol Xinafoate | 昔萘酸沙美特罗 | 94749-08-3 |
| Lurasidone Hydrochloride | 盐酸鲁拉西酮 | 367514-88-3 |
| Vilanterol Trifenatate | 三苯乙酸维兰特罗 | 503070-58-4 |
| Mometasone Furoate Monohydrate | 糠酸莫米松一水物 | 141646-00-6 |
| 3-(4-Chloro-1,2,5-Thiadiazol-3-Yl) Pyridine | 3-(4-氯-1,2,5 -噻二唑-3-基) 吡啶 | 131986-28-2 |
| Levalbuterol Hydrochloride | 盐酸左沙丁胺醇 | 50293-90-8 |
| Fluticasone Furoate | 糠酸氟替卡松 | 397864-44-7 |
| Levosimendan | 左西孟旦 | 141505-33-1 |
| DL-Vortioxetine Lactate | 乳酸伏硫西汀 | 1253056-29-9 |
| Escitalopram Oxalate | 草酸艾司西酞普兰 | 219861-08-2 |
| Salbutamol Sulfate | 硫酸沙丁胺醇 | 51022-70-9 |
| Indobufen | 吲哚布芬 | 63610-08-2 |
| Revefenacin | 瑞维那新/雷芬那辛 | 864750-70-9 |
| Trospium Chloride | 曲司氯铵 | 10405-02-4 |
| Tandospirone Citrate | 枸橼酸坦度螺酮 | 112457-95-1 |
| Indacaterol Maleate | 马来酸茚达特罗 | 753498-25-8 |
| Vortioxetine Hydrobromide | 氢溴酸伏硫西汀 | 960203-27-4 |
| Finerenone | 非奈利酮 | 1050477-31-0 |
| Amisulpride | 氨磺必利 | 71675-85-9 |
| Mirogabalin Besylate | 苯磺酸美洛加巴林 | 1138245-21-2 |
| Minoxidil | 米诺地尔 | 38304-91-5 |
| Eltrombopag Olamine | 艾曲泊帕乙醇胺 | 496775-62-3 |
| Xanomeline Tartrate | 酒石酸呫诺美林 | 152854-19-8 |
| Buspirone Hydrochloride | 盐酸丁螺环酮 | 33386-08-2 |
| 5-Methoxy-1-[4-(Trifluoromethyl)Phenyl]Pentan-1-One | 5-甲氧基-1-[4-(三氟甲基)苯基]-1-戊酮 | 61718-80-7 |
| Agomelatine | 阿戈美拉汀 | 138112-76-2 |
| Glycopyrronium Bromide | 格隆溴铵 | 51186-83-5 |
| Arformoterol Tartrate | 酒石酸阿福特罗 | 200815-49-2 |
| Ipratropium Bromide | 异丙托溴铵 | 66985-17-9 |
| Paliperidone | 帕利哌酮 | 144598-75-4 |
| Safinamide Mesylate | 甲磺酸沙非胺/甲磺酸沙芬酰胺 | 202825-46-5 |
| Umeclidinium Bromide | 乌美溴铵 | 869113-09-7 |
| Tiotropium Bromide Monohydrate | 噻托溴铵一水物 | 411207-31-3 |
联系方式